Grants and Contracts Details
Description
Functionally diverse proteins are generated by alternative splicing of primary transcripts in differentiating
oligodendrocytes. PLP and DM20 are generated through the alternative selection of competing 5' splice
sites in exon 3. As PLP becomes the predominant isoform, the PLP/DM20 ratio increases in differentiated
oligodendrocytes (OL) versus progenitors (OPC). Mutations that alter the ratio of PLP to DM20 cause
neurological disorders in humans [Hobson et aI., 2006; Hobson et aI., 2002]. One of these mutations is a
deletion of a G-rich intronic enhancer (ISE) of the PLP 5' site. In the preliminary studies, we show that exon
38 contains sequences that regulate the PLP/DM20 ratio. A G-rich sequence (M2) is an enhancer of DM20
5' site, while the other exonic sequences enhance PLP 5' site. Although both are G-rich, the ISE and M2 are
functionally distinct. A number of hnRNP's bind to the ISE and M2 and some of them are downregulated in
OL versus OPC. We hypothesize that M2 enhances DM20 5' site in OPC, while the ISE favors the PLP 5'
site in OL as a result of decrease in hnRNP's and changes in the balance of general and cell-specific factors.
Other exon 38 sequences favor PLP 5' site and are both general and cell-specific.
In Aim 1, we will characterize the ISE's function within the full context of the PLP gene in the developing
nervous system of a novel knockin mouse that carries a deletion of the ISE. The cell-specific and
differentiation-dependent function of the ISE will be elucidated in the brain, nerves and nonglial tissues. In
Aim 2, we will characterize the role of M2 in controlling the PLP/DM20 ratio in oligodendrocytes and non-glial
cells by mapping the contribution of the G-sequences and flanking sequences to controlling the PLP/DM20
ratio. The proteins that bind to M2 and to ISE will be identified in biochemical studies and their expression
will be examined in OPC and OL. In Aim 3, we will examine enhancers of PLP 5' site and define their role in
general, cell-specific and differentiation-dependent regulation of PLP/DM20 ratio. In Aim 4, we will examine
the function of hnRNP's in controlling the PLP/DM20 ratio with knock down studies by RNAi. These studies
have broad relevance to oligodendrocyte differentiation, generation of transcript diversity, and alterations of
splicing that causes inherited disorders of myelin.
Status | Finished |
---|---|
Effective start/end date | 1/3/07 → 12/31/12 |
Funding
- National Institute of Neurological Disorders & Stroke: $1,592,731.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.